| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |